BioAtla
BCAB3.3250.75% ( -0.025 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: BioAtla(BCAB) the EBIT is -8.808 M (+49.99%);the EPS is -4.22 (+67.9%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.01B49.99%
----
----
EPS
-4.224767.90%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf